Nintedanib Monograph for Professionals | 合法藥品大搜索
2021年11月22日—Availableasnintedanibesylate;dosageexpressedintermsofnintedanib.Adults.IdiopathicPulmonaryFibrosis.Oral.150mgtwicedaily.
2021年11月22日 — Available as nintedanib esylate; dosage expressed in terms of nintedanib. Adults. Idiopathic Pulmonary Fibrosis. Oral. 150 mg twice daily.
nintedanib esylate usp monograph nintedanib esylate usp monograph kovin tong副作用 欣克潰精錠屈臣氏價格 興和克潰精錠ptt 興和克潰精錠價錢 克醣錠價格 立克醣副作用 胃樂順功效 dorsiflex機轉
(PDF) Development and validation of a simple and sensitive ... | 合法藥品大搜索
2015年9月2日 — Chemical Structures of Nintedanib Esylate ... indicating RP-HPLC assay method for determination of Nintedanib ... USP Plate Count. Read More
205832s000lbl.pdf | 合法藥品大搜索
Nintedanib esylate is a bright yellow powder with an empirical formula of C31H33N5O4·C2H6O3S and a molecular weight of 649.76 g/mol. OFEV capsules for oral ... Read More
Australian Public Assessment Report for Nintedanib esilate | 合法藥品大搜索
2016年2月8日 — The recommended dose of nintedanib for the treatment of IPF is 150 mg twice daily ... pharmacopoeial monograph. Read More
Label: OFEV | 合法藥品大搜索
OFEV capsules contain nintedanib, a kinase inhibitor [see Mechanism of Action (12.1)]. Nintedanib is presented as the ethanesulfonate salt (esylate), with the ... Read More
Nintedanib Monograph for Professionals | 合法藥品大搜索
2021年11月22日 — Available as nintedanib esylate; dosage expressed in terms of nintedanib. Adults. Idiopathic Pulmonary Fibrosis. Oral. 150 mg twice daily. Read More
Nintedanib | 合法藥品大搜索
Nintedanib | C31H33N5O4 | CID 135423438 - structure, chemical names, physical and ... 505 of the Federal Food, Drug, and Cosmetic Act. /Nintedanib esylate/. Read More
ofev-epar-product-information | 合法藥品大搜索
Ofev 150 mg soft capsules. One soft capsule contains 150 mg nintedanib (as esilate). Excipient with known effect. Each 150 mg soft capsule contains 1.8 mg of ... Read More
Priority Monographs | 合法藥品大搜索
602, NINTEDANIB ESYLATE, New. 603, NISOLDIPINE EXTENDED-RELEASE TABLETS, New. 604, NITAZOXANIDE FOR ORAL SUSPENSION, New. 605, NITAZOXANIDE TABLETS, New. Read More
Validated HPTLC Method for the Determination of Nintedanib ... | 合法藥品大搜索
由 D Dutta 著作 · 2018 · 被引用 3 次 — Abstract: A simple, rapid, precise and accurate High-Performance Thin Layer Chromatography. (HPTLC) method was developed and validated for ... Read More
相關資訊整理
【益比宗顆粒】頭痛、關節痛、風濕關節炎、生理痛、肌肉痛、手術後疼痛、感冒、一般解熱、鎮咳
藥品名稱:益比宗顆粒許可證字號:衛署藥製字第017811號許可證種類:製 劑適應症:頭痛、關節痛、風濕關節炎、生理痛、肌肉痛、...
【抑肺纖軟膠囊100毫克】1、特發性肺纖維化(idiopathic pulmonary fibrosis):適用於治療特發性肺纖維化(IPF)。2、與全身性硬化症有關之間質性肺病:適用於減緩與全身性硬化症有關之間質性肺病(SSc-ILD)病人的肺功能下降速度。3、慢性漸進性纖維化間質性肺病(PF-ILD)。
藥品名稱:抑肺纖軟膠囊100毫克許可證字號:衛部藥輸字第026569號許可證種類:製 劑適應症:1、特發性肺纖維化(idiopathicpulmo...
【肺特治】結核病
藥品名稱:肺特治許可證字號:衛署藥輸字第000214號許可證種類:原料藥適應症:結核病劑型:藥品類別:製劑原料主成分略述:ISONIAZ...
【克羅纖維化】抗膽醇血症
藥品名稱:克羅纖維化許可證字號:衛署藥輸字第004564號許可證種類:原料藥適應症:抗膽醇血症劑型:藥品類別:製劑原料主成分略述...
【比樂舒活錠200毫克】治療特發性肺纖維化
藥品名稱:比樂舒活錠200毫克許可證字號:衛部藥輸字第026734號許可證種類:製 劑適應症:治療特發性肺纖維化劑型:藥品類別:須...
【抑肺纖軟膠囊150毫克】1、特發性肺纖維化(idiopathic pulmonary fibrosis):適用於治療特發性肺纖維化(IPF)。2、與全身性硬化症有關之間質性肺病:適用於減緩與全身性硬化症有關之間質性肺病(SSc-ILD)病人的肺功能下降速度。3、慢性漸進性纖維化間質性肺病(PF-ILD)。
藥品名稱:抑肺纖軟膠囊150毫克許可證字號:衛部藥輸字第026568號許可證種類:製 劑適應症:1、特發性肺纖維化(idiopathicpulmo...
【測試藥輸6】緩解感冒之各種症狀(喀痰,流鼻水,鼻塞、打噴嚏)
藥品名稱:測試藥輸6許可證字號:衛署藥輸字第999006號許可證種類:製 劑適應症:緩解感冒之各種症狀(喀痰,流鼻水,鼻塞、打...